3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
56
Precursor Cell Lymphoblastic Leukemia-Lymphoma
45
Myelodysplastic Syndromes
41
Leukemia, Lymphocytic, Chronic, B-Cell
30
Lymphoma, Non-Hodgkin
27
Multiple Myeloma
22
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
22
Hodgkin Disease
20
Leukemia
17
Myeloproliferative Disorders
16
Recurrence
15
Lymphoma, Follicular
15
Leukemia, Biphenotypic, Acute
15
Melanoma
14
Lymphoma, Mantle-Cell
14
Lymphoma
14
Leukemia, Myelomonocytic, Chronic
14
Lymphoma, Large B-Cell, Diffuse
13
Hematologic Neoplasms
13
Burkitt Lymphoma
11
Anemia, Refractory, with Excess of Blasts
11
Lymphoma, B-Cell, Marginal Zone
10
Lymphoma, B-Cell
10
Primary Myelofibrosis
8
Neoplasm, Residual
7
Neoplasm Metastasis
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Neuroblastoma
6
Neoplasms
6
Graft vs Host Disease
6
Interventions
Gemcitabine
56
pembrolizumab
51
Cisplatin
43
Magnetic Resonance Spectroscopy
27
enfortumab vedotin
23
Specimen Handling
22
Nivolumab
22
Cystectomy
18
durvalumab
16
Carboplatin
16
avelumab
14
Mitomycin
14
atezolizumab
13
Docetaxel
13
Cystoscopy
12
Fluorouracil
11
Radiation
9
Transurethral Resection of Bladder
8
Radiotherapy
8
Ipilimumab
8
sacituzumab govitecan
7
Standard of Care
7
Radiosurgery
7
Paclitaxel
7
Immunoglobulin G
7
Disulfides
7
erdafitinib
6
cemiplimab
6
Surveys and Questionnaires
6
Surgical Procedures, Operative
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
fludarabine phosphate
×
1 year
×
Clear all
No trials found.